Heart failure is among the fastest-growing cardiovascular conditions worldwide, and its chronic, progressive nature ensures steady demand for pharmacological treatment. Understanding what's fueling the market helps pharmaceutical companies, investors, and healthcare stakeholders plan effectively.
A central driver of the congestive heart failure drugs market is demographic. Populations are...
